Unity Biotechnology, Inc.
UBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -95.1% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | -823.7% | 39.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -16,411.4% | -1,142.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -18,842.8% | -1,269.3% |
| EPS Diluted | -1.54 | -2.7 | -4.68 | -10.9 |
| % Growth | 43% | 42.3% | 57.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |